Clinical Trial: Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547826) titled 'Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies' on April 17.

Brief Summary: Objectives

* Primary:

* To measure the reduction in VP shunt infection rates using topical vancomycin powder.

* Secondary:

* To compare efficacy across different Etiological Strata (Congenital, Post-hemorrhagic, post-inflammatory).

* To analyze the microbiological profile of failed cases.

* To compare the "Time-to-Infection" and shunt survival rates between the study and control groups using Kaplan-Meier analysis.

* To evaluate the cost-effectivene...